2.1 Pre-Procedure Patient Evaluation & Laboratory Assessment
Key Takeaways
SIR uses low and high procedural bleeding-risk groups. For high-risk procedures, the suggested INR correction threshold is in the 1.5–1.8 range and depends on the procedure.
In healthy elective patients, ASA fasting guidance includes 2 hours for clear liquids and 6 hours for a light meal. Assess delayed gastric emptying or emergencies individually.
Use the specific medication, bleeding and thrombosis risks, renal function and clinician orders to verify interruption and resumption.
Review the kidney function trend, presence of AKI, iodine-based contrast route and metformin plan. The ACR IV recommendations and FDA product labeling differ.
Verify documentation of informed consent and raise questions with the authorized clinician. Confirm identity, procedure and site during the team time-out.
2.1 Pre-Procedure Patient Evaluation & Laboratory Assessment
Clinical Core: Before the procedure, identify the plan, baseline findings and any concern that requires clarification. Match medication and laboratory checks to the procedure and the patient's risks. Verify consent, the sedation plan, last oral intake and preparations for contrast administration.
Pre-Procedure Patient Assessment & Baseline Examination
History and Baseline Findings
Review the indication, prior vascular procedures and imaging, access history, and changes in cardiopulmonary status. A patient with orthopnea may need a different positioning or sedation plan. Verify medication names, doses and last administration times. Ask about anticoagulants, antiplatelets, metformin and other relevant diabetes drugs, previous contrast reactions and prior anesthesia or sedation problems. Record baseline vital signs and communicate marked abnormalities. Document the pertinent distal pulses, sensation and motor function before draping so a later change can be compared with baseline.
If a pulse is difficult to palpate, assess Doppler flow and document which artery was checked and how. An absent palpable pulse can reflect perfusion, pre-existing arterial disease or difficulty finding the artery. A resting leg artery can show a multiphasic high-resistance waveform. Delayed, damped monophasic flow may suggest upstream disease, but phasicity alone cannot grade a stenosis. Describe the actual finding, the side and the baseline rather than inferring a specific blockage from a pulse grade. For current coronary access guidance and historical collateral testing, see the vascular access lesson.
Contrast Reaction History
Ask which contrast agent was given, what symptoms occurred, how soon they started and what treatment was needed. Some immediate allergic-like reactions are IgE-mediated and others follow different pathways. An isolated shellfish allergy does not confer a special risk from iodinated contrast or indicate premedication. Warmth or nausea can be physiologic symptoms. Record the clinical features instead of labeling the patient as allergic to iodine.
A prior immediate reaction should prompt a review of severity and the original agent with the clinical team. Verify any planned agent substitution, alternate imaging, premedication or emergency coverage before the study. Review the contrast reaction lesson for severity-specific decisions.
Pre-Sedation Fasting Guidelines (NPO Status)
Fasting reduces the amount of gastric contents that might be aspirated during sedation. For healthy patients undergoing elective procedures, the ASA's 2017 guidelines and 2023 modular update support these minimum intervals. Record the type, amount and time of actual intake and notify the sedation team if it differs from instructions.
| Intake | Minimum fasting period in the ASA elective guideline |
|---|---|
| Clear liquids such as water, pulp-free juice or black coffee | 2 hours |
| Breast milk | 4 hours |
| Infant formula, nonhuman milk or a light meal such as plain toast and a clear liquid | 6 hours |
| Fried or fatty food or a meal containing meat | 8 hours or more may be needed, depending on type and amount |
The sedation team assesses patients with delayed gastric emptying or elevated aspiration risk individually. Examples include gastroparesis, gastrointestinal obstruction and emergency cases. If a patient reports a late meal or symptoms that raise concern about gastric emptying, communicate them. The clinician considers urgency, the planned depth of sedation and aspiration risk before choosing how and when to proceed. The fasting table applies to anesthesia and sedation; IV contrast administration by itself does not require fasting under the ACR contrast manual.
Medicolegal Principles of Informed Consent
Informed Consent and Team Verification
Informed consent is a discussion and a voluntary decision. The authorized clinician assesses decision-making capacity and discusses the procedure's expected benefits, risks, alternatives and the option of declining. If a patient lacks capacity, the team verifies a legally authorized representative under applicable rules. In some emergencies, urgent care may proceed when the patient cannot decide, no surrogate is available and delay would endanger the patient. Document the circumstances according to applicable law and institutional policy.
For U.S. hospitals, the CMS interpretive guidance calls for hospital policies that identify who may obtain consent and how it is documented. The technologist verifies that consent is documented and matches the planned procedure, and brings missing information or substantive patient questions to the authorized clinician before sedation or initiation of the procedure. A signature witness, when used, follows facility policy. During the time-out the team verifies patient identity, procedure and site as applicable and resolves discrepancies before proceeding.
Coagulation Assessment & SIR Hemostatic Thresholds
The Society of Interventional Radiology (SIR) separates percutaneous procedures into low and high bleeding-risk groups. Review the planned procedure, access, expected sheath size and factors such as bleeding history, liver disease and anticoagulant use. The 2019 SIR thresholds are recommendations for specified circumstances. They are based largely on limited evidence and clinical consensus.
| SIR bleeding-risk example | Testing and action in the 2019 recommendations |
|---|---|
| Low risk, such as nontunneled venous access or superficial drainage | Routine coagulation tests are often unnecessary in patients without risk factors. When correction is indicated, the general INR range is 2.0–3.0 or less. For low-risk arterial access, the proposed INR limits are below 1.8 for femoral and below 2.2 for radial access. |
| High risk, such as solid-organ biopsy, new biliary intervention or aortic intervention | Obtain appropriate coagulation testing. The suggested INR correction target is at or below a threshold in the 1.5–1.8 range, selected for the procedure. |
The 2025 AABB/ICTMG platelet guidance for adults in interventional radiology recommends considering the procedure's bleeding risk. Its transfusion thresholds are a platelet count below 20,000/µL for low-risk procedures and below 50,000/µL for high-risk procedures. Patients with chronic liver disease may require a separate assessment. INR alone cannot reliably predict procedure-related bleeding in cirrhosis.
What Common Tests Measure
| Test | How to interpret it in the procedure workflow |
|---|---|
| Platelet count | Measures the number of platelets. Antiplatelet therapy can alter function even when the count is normal. |
| PT/INR | INR standardizes prothrombin time and is used to monitor the effect of warfarin. It is not a reliable measure of residual DOAC effect. |
| aPTT | Can be used to monitor IV unfractionated heparin under a calibrated lab protocol. Its utility depends on the drug, assay and clinical setting. |
| ACT | A whole-blood point-of-care test for procedures using high-dose heparin. Its target depends on the procedure and the instrument. |
| Fibrinogen | Measures an essential clotting protein. The measurement can help the team assess selected cases of bleeding or coagulopathy. |
Renal Function & Complete Blood Count (CBC)
Kidney Function and Iodinated Contrast
Review the creatinine trend, reported estimated glomerular filtration rate (eGFR), evidence of acute kidney injury (AKI) and the contrast route. An eGFR calculated from creatinine is less informative when creatinine is changing rapidly. For IV iodine-based contrast, the ACR/NKF consensus supports prophylaxis with IV isotonic saline in patients with AKI or eGFR below 30 mL/min/1.73 m² who are not on maintenance dialysis, when it is safe to give fluid. Individual high-risk patients with stable eGFR of 30–44 may warrant prophylaxis. Account for fluid overload risk. Intra-arterial procedures involve additional considerations such as arterial manipulation and possible renal embolization. Use the procedural team's plan for that route.
Metformin Reconciliation
Ask when metformin was last taken and whether IV contrast or arterial catheterization is planned. ACR guidance and U.S. product labeling use different criteria. Document the kidney function trend and verify any hold, follow-up testing and restart time with the prescribing and procedural teams. The contrast reaction lesson explains how to apply those criteria to the actual route.
Complete Blood Count (CBC)
A baseline hemoglobin and hematocrit provide context for trends when bleeding is suspected. Significant blood loss can occur before a drop is measured. Assess symptoms and vital signs promptly. A white blood cell count can support the evaluation of infection alongside examination, temperature and other tests. Leukocytosis alone does not establish bacteremia. Communicate suspected active infection to the clinician when an elective implant is planned.
Pre-Procedure Medication Holding & Reversal Guidelines
Determine why the patient takes each drug, when they last took it, when to hold or continue it, and who will direct resumption after hemostasis. Decisions balance bleeding from the procedure against risks such as stroke, venous thromboembolism and coronary stent thrombosis. Verify the plan with the care team, especially when the instructions differ from the patient's report.
| Drug or class | What changes the procedure plan |
|---|---|
| Warfarin | When interruption is chosen for an elective high-bleeding-risk IR procedure, the 2019 SIR medication table gives a 5-day hold and an INR goal of 1.8 or less. The specific procedure may require a lower target. Check the INR and the agreed plan. |
| Apixaban, rivaroxaban and dabigatran | Use drug-specific timing, procedure bleeding risk and creatinine clearance. Impaired clearance can lengthen interruption, particularly for dabigatran. A clinician may order a drug-specific test in selected urgent situations. |
| Unfractionated heparin and low-molecular-weight heparin | The route, last dose, renal function for LMWH and procedural risk determine the hold interval and whether a lab test is useful. Reversal is a separate decision. |
| Aspirin and P2Y12 inhibitors | Balance bleeding risk against the indication and timing of any recent coronary stent. Confirm interruption or continuation with the team managing antiplatelet therapy. |
For urgent bleeding, alert the team to the agent and time of exposure. Reversal availability can change. FDA reported that AstraZeneca would stop manufacturing or selling andexanet alfa (Andexxa) in the United States after December 22, 2025. Use the clinician-directed current facility reversal protocol.
Worked schedule. A patient scheduled for an elective biliary procedure reports taking a dose of warfarin yesterday even though the team ordered a five-day interruption. Document the last dose, check the ordered INR and contact the procedural team. An existing schedule does not establish that the laboratory target has been met.
An adult without chronic liver disease is scheduled for a new percutaneous biliary drain. Which statement best reflects SIR laboratory guidance for this high-bleeding-risk procedure?
Use the same INR target of 2.0–3.0 used for some low-risk procedures, regardless of the access route
Obtain coagulation testing, choose an INR correction threshold in the 1.5–1.8 range according to the procedure, and consider platelet transfusion below 50,000/µL
Apply a common INR target of 1.1 and a platelet threshold of 100,000/µL for all high-risk image-guided procedures
Use platelet count alone because INR has no role in preprocedure assessment in this setting
A healthy adult without delayed gastric emptying or other aspiration risk factors is scheduled for elective pelvic embolization with moderate sedation. Which minimum intervals apply to plain water and a light meal of toast with a clear drink under ASA guidance?
Water 4 hours and light meal 8 hours
Water 6 hours and light meal 12 hours
Water 2 hours and light meal 6 hours
Water 1 hour and light meal 4 hours
The team uses the SIR medication table for an elective high-bleeding-risk biliary procedure. It decides to interrupt warfarin without bridging and documents an INR target of 1.8 or less. Which plan matches the table and verifies the target?
Follow the ordered 5-day interruption and confirm the actual INR before the procedure
Follow a 24-hour interruption and use a normal platelet count as the measure of warfarin effect
Continue warfarin unchanged and check only the aPTT
Use the timing of the last dose to substitute for the planned INR check
Sections you finish are checked off in the contents.